Bristol-Myers Squibb, Nordic Bioscience deal

Bristol-Myers Squibb and Nordic Bioscience partnered to develop translational biomarkers and diagnostics to detect non-alcoholic steatohepatitis (NASH). Both companies will have the ability to utilize...